Recombinant SPARC anticorps (C-Term)

N° du produit ABIN8093457

Cet anticorps anti-SPARC Monoclonal Souris (Clone rOSTN-9835) (ABIN8093457) détecte spécifiquement SPARC dans WB et IHC. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant SPARC anticorps (C-Term) (ABIN8093457)

Antigène: SPARC (Secreted Protein, Acidic, Cysteine-Rich (Osteonectin) (SPARC))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SPARC est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Clone: ROSTN-9835

Détail du produit anti-SPARC anticorps

Épitope: C-Term

Fonction: SPARC Antibody / Secreted protein acidic and cysteine rich

Immunogène: A recombinant fragment corresponding to the C-terminus of human SPARC protein (exact sequence is proprietary) was used as the immunogen for the BM-40/SPARC antibody.

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal dilution of the BM-40/SPARC antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.05 % BSA, 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: BM-40/SPARC antibody with sodium azide store at 2 to 8oC, antibody without sodium azide store at -20 to -80oC.

Détails sur SPARC

Antigène: SPARC (Secreted Protein, Acidic, Cysteine-Rich (Osteonectin) (SPARC))

Autre désignation: SPARC

Sujet: BM-40 antibody, also known as SPARC antibody, recognizes Secreted protein acidic and rich in cysteine, a secreted matricellular glycoprotein that regulates extracellular matrix organization and cell-matrix communication. The human SPARC gene is located on chromosome 5q33.1 and encodes a protein widely referred to in the literature as Osteonectin and Basement membrane protein 40. SPARC is secreted into the extracellular space and localizes to basement membranes and stromal compartments, where it modulates interactions between cells and the surrounding matrix rather than functioning as a structural scaffold.

Secreted protein acidic and rich in cysteine plays a key role in collagen binding, matrix assembly, and regulation of cell adhesion and migration. It is highly expressed in connective tissues, bone, activated fibroblasts, and endothelial cells. In skeletal biology, Osteonectin is abundant in osteoblasts and bone matrix, contributing to collagen fibrillogenesis and mineralization processes. A BM-40 antibody is frequently used in studies investigating extracellular matrix remodeling, tumor microenvironment dynamics, angiogenesis, and fibrotic disease due to SPARC's involvement in stromal activation and matrix deposition.

Structurally, SPARC contains an acidic N-terminal domain, a follistatin-like domain, and a C-terminal extracellular calcium-binding domain with EF-hand motifs. These domains support calcium binding and mediate interactions with collagens, albumin, and growth factors. Through these molecular interactions, Secreted protein acidic and rich in cysteine influences signaling pathways such as TGF-beta signaling and integrin-mediated adhesion cascades, impacting tissue remodeling and vascular responses.

In cancer research, elevated SPARC expression is commonly observed in desmoplastic stroma associated with breast, pancreatic, colorectal, and ovarian carcinomas. Expression is often detected in tumor-associated fibroblasts and matrix-rich regions, where SPARC contributes to extracellular matrix reorganization. Depending on tumor context, SPARC may be linked to invasion, stromal remodeling, or modulation of growth factor signaling. Beyond oncology, SPARC is upregulated during wound healing and in fibrotic disorders affecting liver, lung, and kidney, reflecting its broader role in tissue repair and matrix turnover. During embryogenesis, SPARC expression is detected in tissues undergoing active morphogenesis and vascular development.

Clone rOSTN/9835 is a recombinant monoclonal antibody developed to recognize SPARC in research applications. A BM-40 antibody supports investigation of extracellular matrix biology, connective tissue remodeling, and stromal cell function. This antibody targets SPARC in research settings and is suitable for studies focused on fibrosis, angiogenesis, skeletal biology, and tumor-associated stromal responses.

UniProt: P09486

Pathways: Autophagy